Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
ABSTRACT Breast cancer is among the most common cancers in U.S. women. Epidermal growth factor receptor inhibitors (EGFRIs) target pathways driving tumor growth but frequently cause dermatologic toxicities that impact quality of life and treatment adherence. This review summarizes the clinical featu...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2025-12-01
|
| シリーズ: | Clinical and Translational Science |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1111/cts.70432 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|